月経前不快気分障害（PMDD）の世界市場 2019年版：種類別（テーブル製品、インジェクト製品、その他）、用途別（病院、クリニック、その他）

• 英文タイトル：Global Premenstrual Dysphoric Disorder (PMDD) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：C-GIR20G2962 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

「月経前不快気分障害（PMDD）の世界市場2019年」は、グローバルにおける月経前不快気分障害（PMDD）市場を展望するレポートです。月経前不快気分障害（PMDD）のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・月経前不快気分障害（PMDD）の市場概観 ・月経前不快気分障害（PMDD）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・月経前不快気分障害（PMDD）の企業別販売動向、市場シェア、市場集中度、競争動向 ・月経前不快気分障害（PMDD）の世界市場規模 ・月経前不快気分障害（PMDD）の北米市場分析（アメリカ、カナダ、メキシコ等） ・月経前不快気分障害（PMDD）のアメリカ市場規模推移 ・月経前不快気分障害（PMDD）のカナダ市場規模推移 ・月経前不快気分障害（PMDD）のメキシコ市場規模推移 ・月経前不快気分障害（PMDD）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・月経前不快気分障害（PMDD）のドイツ市場規模推移 ・月経前不快気分障害（PMDD）のイギリス市場規模推移 ・月経前不快気分障害（PMDD）のロシア市場規模推移 ・月経前不快気分障害（PMDD）のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・月経前不快気分障害（PMDD）の日本市場規模推移 ・月経前不快気分障害（PMDD）の中国市場規模推移 ・月経前不快気分障害（PMDD）の韓国市場規模推移 ・月経前不快気分障害（PMDD）のインド市場規模推移 ・月経前不快気分障害（PMDD）の東南アジア市場規模推移 ・月経前不快気分障害（PMDD）の南米市場分析（ブラジル、アルゼンチン等） ・月経前不快気分障害（PMDD）の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・月経前不快気分障害（PMDD）の種類別分析/販売量、売上、市場シェア（テーブル製品、インジェクト製品、その他） ・月経前不快気分障害（PMDD）の用途別分析/市場規模（病院、クリニック、その他） ・月経前不快気分障害（PMDD）の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・月経前不快気分障害（PMDD）の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Premenstrual Dysphoric Disorder (PMDD) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Premenstrual Dysphoric Disorder (PMDD).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Premenstrual Dysphoric Disorder (PMDD) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Premenstrual Dysphoric Disorder (PMDD) market by product type and applications/end industries.

Market Segment by Companies, this report covers
Teva
Mylan
Bayer
Eli Liliy
Bristol Laboratories
Pfizer
Apotex
GSK
Allergan

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Table Product
Inject Product
Others

Market Segment by Applications, can be divided into
Hospital
Clinic
Others

レポート目次

---

Table of Contents

1 Premenstrual Dysphoric Disorder (PMDD) Market Overview
1.1 Product Overview and Scope of Premenstrual Dysphoric Disorder (PMDD)
1.2 Classification of Premenstrual Dysphoric Disorder (PMDD) by Types
1.2.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Comparison by Types (2019-2024)
1.2.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Types in 2018
1.2.3 Table Product
1.2.4 Inject Product
1.2.5 Others
1.3 Global Premenstrual Dysphoric Disorder (PMDD) Market by Application
1.3.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Premenstrual Dysphoric Disorder (PMDD) Market by Regions
1.4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Premenstrual Dysphoric Disorder (PMDD) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Premenstrual Dysphoric Disorder (PMDD) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Premenstrual Dysphoric Disorder (PMDD) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Premenstrual Dysphoric Disorder (PMDD) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Premenstrual Dysphoric Disorder (PMDD) Status and Prospect (2014-2024)
1.5 Global Market Size of Premenstrual Dysphoric Disorder (PMDD) (2014-2024)
2 Company Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
2.4 Eli Liliy
2.4.1 Business Overview
2.4.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol Laboratories
2.5.1 Business Overview
2.5.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
2.7 Apotex
2.7.1 Business Overview
2.7.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
2.8 GSK
2.8.1 Business Overview
2.8.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GSK Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
2.9 Allergan
2.9.1 Business Overview
2.9.2 Premenstrual Dysphoric Disorder (PMDD) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Premenstrual Dysphoric Disorder (PMDD) Market Competition, by Players
3.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Premenstrual Dysphoric Disorder (PMDD) Players Market Share
3.2.2 Top 10 Premenstrual Dysphoric Disorder (PMDD) Players Market Share
3.3 Market Competition Trend
4 Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions
4.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue and Market Share by Regions
4.2 North America Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
4.3 Europe Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
4.5 South America Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
5 North America Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries
5.1 North America Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries (2014-2019)
5.2 USA Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
5.3 Canada Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
5.4 Mexico Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
6 Europe Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries
6.1 Europe Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries (2014-2019)
6.2 Germany Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
6.3 UK Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
6.4 France Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
6.5 Russia Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
6.6 Italy Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries
7.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries (2014-2019)
7.2 China Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
7.3 Japan Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
7.4 Korea Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
7.5 India Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
8 South America Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries
8.1 South America Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries (2014-2019)
8.2 Brazil Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
8.3 Argentina Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
8.4 Colombia Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Premenstrual Dysphoric Disorder (PMDD) by Countries
9.1 Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
9.3 UAE Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
9.4 Egypt Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
9.6 South Africa Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
10 Global Premenstrual Dysphoric Disorder (PMDD) Market Segment by Type
10.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue and Market Share by Type (2014-2019)
10.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Forecast by Type (2019-2024)
10.3 Table Product Revenue Growth Rate (2014-2024)
10.4 Inject Product Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Premenstrual Dysphoric Disorder (PMDD) Market Segment by Application
11.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Application (2014-2019)
11.2 Premenstrual Dysphoric Disorder (PMDD) Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2024)
12.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2024)
12.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Forecast by Regions (2019-2024)
12.3 North America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
12.4 Europe Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
12.6 South America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Premenstrual Dysphoric Disorder (PMDD) Picture
Table Product Specifications of Premenstrual Dysphoric Disorder (PMDD)
Table Global Premenstrual Dysphoric Disorder (PMDD) and Revenue (Million USD) Market Split by Product Type
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Types in 2018
Figure Table Product Picture
Figure Inject Product Picture
Figure Others Picture
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) by Application (2014-2024)
Figure Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Market Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) and Growth Rate (2014-2024)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table Teva Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table Mylan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table Bayer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Liliy Basic Information, Manufacturing Base and Competitors
Table Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol Laboratories Basic Information, Manufacturing Base and Competitors
Table Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table Pfizer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table Apotex Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table GSK Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Premenstrual Dysphoric Disorder (PMDD) Type and Applications
Table Allergan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2017-2018)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) by Players (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Players (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Players in 2017
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Players in 2018
Figure Global Top 5 Players Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share in 2018
Figure Global Top 10 Players Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share in 2018
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) by Regions (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Regions (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Regions (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Regions in 2018
Figure North America Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure South America Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Table North America Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries (2014-2019)
Table North America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries (2014-2019)
Figure North America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries (2014-2019)
Figure North America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries in 2018
Figure USA Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Canada Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Mexico Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Table Europe Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) by Countries (2014-2019)
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries (2014-2019)
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries in 2018
Figure Germany Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure UK Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure France Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Russia Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Italy Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries in 2018
Figure China Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Japan Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Korea Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure India Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Table South America Premenstrual Dysphoric Disorder (PMDD) Revenue by Countries (2014-2019)
Table South America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries (2014-2019)
Figure South America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries (2014-2019)
Figure South America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries in 2018
Figure Brazil Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Argentina Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Colombia Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure UAE Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Egypt Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure Nigeria Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Figure South Africa Premenstrual Dysphoric Disorder (PMDD) Revenue and Growth Rate (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) by Type (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Type (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Type (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Type in 2018
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue Forecast by Type (2019-2024)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share Forecast by Type (2019-2024)
Figure Global Table Product Revenue Growth Rate (2014-2019)
Figure Global Inject Product Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Application (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Application (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Application (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Application in 2018
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue Forecast by Application (2019-2024)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
Figure South America Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Revenue Market Forecast (2019-2024)

---